Acquisitions18 Mar 2025, 06:01 pm
Sun Pharmaceutical Completes 100% Acquisition of Antibe Therapeutics Inc. for CAD 4.5 Million
AI Summary
Sun Pharmaceutical Industries Limited has announced the completion of 100% acquisition of Antibe Therapeutics Inc., Canada by its subsidiary, TARO Pharmaceuticals Inc. The total consideration for the acquisition is CAD 4.5 million. This announcement is pursuant to the intimation made by the company on January 16, 2025.
Key Highlights
- Sun Pharmaceutical Industries Limited has completed a 100% acquisition of Antibe Therapeutics Inc., Canada through its subsidiary, TARO Pharmaceuticals Inc.
- The total consideration for the acquisition is CAD 4.5 million.
- This announcement is a follow-up to the intimation made by the company on January 16, 2025.